AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
5.03
-0.08 (-1.57%)
At close: Feb 27, 2026, 4:00 PM EST
5.07
+0.04 (0.80%)
After-hours: Feb 27, 2026, 4:17 PM EST
AVITA Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 71.61 | 64.25 | 50.14 | 34.42 | 33.03 | Upgrade
|
| Revenue Growth (YoY) | 11.45% | 28.14% | 45.68% | 4.23% | 12.98% | Upgrade
|
| Cost of Revenue | 12.79 | 9.09 | 7.78 | 6.04 | 6.1 | Upgrade
|
| Gross Profit | 58.82 | 55.16 | 42.36 | 28.38 | 26.92 | Upgrade
|
| Selling, General & Admin | 80.51 | 91.39 | 65.63 | 45.24 | 37.92 | Upgrade
|
| Research & Development | 20.84 | 20.36 | 20.82 | 13.86 | 15.67 | Upgrade
|
| Other Operating Expenses | - | - | -1.43 | -3.22 | -1.59 | Upgrade
|
| Operating Expenses | 101.35 | 111.75 | 85.02 | 55.89 | 52 | Upgrade
|
| Operating Income | -42.53 | -56.59 | -42.66 | -27.51 | -25.08 | Upgrade
|
| Interest Expense | -8.3 | -5.36 | -1.92 | -0.02 | -0.03 | Upgrade
|
| Interest & Investment Income | 0.9 | 2.7 | 3.1 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.02 | -0.02 | -0.02 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 2.78 | -0.02 | -0.43 | 0.89 | 0.05 | Upgrade
|
| EBT Excluding Unusual Items | -47.18 | -59.29 | -41.92 | -26.63 | -25.06 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 9.4 | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | -0.04 | Upgrade
|
| Other Unusual Items | -1.4 | -2.5 | -2.8 | - | - | Upgrade
|
| Pretax Income | -48.58 | -61.79 | -35.32 | -26.63 | -25.1 | Upgrade
|
| Income Tax Expense | 0.01 | 0.05 | 0.07 | 0.04 | 0.04 | Upgrade
|
| Earnings From Continuing Operations | -48.59 | -61.85 | -35.38 | -26.67 | -25.14 | Upgrade
|
| Net Income | -48.59 | -61.85 | -35.38 | -26.67 | -25.14 | Upgrade
|
| Net Income to Common | -48.59 | -61.85 | -35.38 | -26.67 | -25.14 | Upgrade
|
| Shares Outstanding (Basic) | 28 | 26 | 25 | 25 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 26 | 25 | 25 | 24 | Upgrade
|
| Shares Change (YoY) | 7.64% | 2.18% | 1.32% | 2.64% | 7.42% | Upgrade
|
| EPS (Basic) | -1.74 | -2.39 | -1.40 | -1.07 | -1.03 | Upgrade
|
| EPS (Diluted) | -1.74 | -2.39 | -1.40 | -1.07 | -1.03 | Upgrade
|
| Free Cash Flow | -32.2 | -58.11 | -39.39 | -19.54 | -18.52 | Upgrade
|
| Free Cash Flow Per Share | -1.16 | -2.25 | -1.55 | -0.78 | -0.76 | Upgrade
|
| Gross Margin | 82.13% | 85.85% | 84.48% | 82.45% | 81.52% | Upgrade
|
| Operating Margin | -59.40% | -88.08% | -85.07% | -79.91% | -75.93% | Upgrade
|
| Profit Margin | -67.85% | -96.25% | -70.56% | -77.47% | -76.13% | Upgrade
|
| Free Cash Flow Margin | -44.97% | -90.44% | -78.56% | -56.77% | -56.09% | Upgrade
|
| EBITDA | -40.24 | -55.47 | -42.02 | -26.94 | -24.4 | Upgrade
|
| EBITDA Margin | -56.19% | -86.33% | -83.81% | -78.26% | -73.89% | Upgrade
|
| D&A For EBITDA | 2.29 | 1.13 | 0.63 | 0.57 | 0.67 | Upgrade
|
| EBIT | -42.53 | -56.59 | -42.66 | -27.51 | -25.08 | Upgrade
|
| EBIT Margin | -59.40% | -88.08% | -85.07% | -79.91% | -75.93% | Upgrade
|
| Revenue as Reported | 71.61 | 64.25 | 50.14 | - | - | Upgrade
|
| Advertising Expenses | 0.49 | 0.54 | 0.4 | 0.22 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.